Menu

Cancer

HomeAll PostsCancer

AOA Dx Secures $17M to Advance Its Ovarian Cancer Diagnostic Test

Cancer, Investment, News October 11, 2023
Share

AOA Dx, a biotech startup based in the United States, has successfully raised $17M to accelerate the development of its liquid biopsy test for ovarian cancer. This round was led by Good Growth Capital with participation from industry leading investors including RH Capital, Y Combinator, Astia, Adaptive Capital Partners, Gore Range Capital, LongeVC, The Helm, VU Venture Partners, FemHealth Ventures, CANCER FUND along with strategic diagnostic investors, including Labcorp Venture Fund. AOA Dx’s innovative approach revolves around…

Breast Cancer Awareness Month: Why Nabta Health Founder Sophie Smith Is Asking You to #UnthinkThePink

Cancer, Ecosystem, News October 4, 2023
Share

Breast Cancer Awareness Month, observed every October, is a globally recognized initiative aimed at raising awareness about breast cancer, the most prevalent cancer in women worldwide. During this month, numerous activities and campaigns are usually organized to promote early detection and screening. Pink ribbons, a symbol of breast cancer awareness, are prominently displayed, while landmarks are often illuminated in pink to draw…

Asieris’ Cevira, the First Non-Vaccine Investigational Product for Cervical HSIL, Has Achieved Its Primary Endpoint

Biotech, Cancer, News, Pharma September 21, 2023
Share

In a stride forward for women’s health and cervical cancer prevention, Asieris Pharmaceuticals has declared the successful completion of its Phase III clinical trial for APL-1702 (Cevira), a non-surgical treatment aimed at cervical high-grade squamous intraepithelial lesions (HSIL). This significant milestone could shift the paradigm in treating this precancerous condition, offering a less invasive alternative to surgery, and may particularly benefit women…

NK:IO Secures £1.2M in Latest Funding Round to Advance Ovarian Cancer Treatment with Cell Therapy

Biotech, Cancer, Investment, News September 12, 2023
Share

NK:IO, a startup working on natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised an additional £1.2M in funding to advance its work. This brings total equity financing to £3.2M and will enable the company to reach key milestones in progressing its differentiated NK cell therapy candidates into development. The £3.2M…

Spotlight: Ovarian Cancer

Cancer, News, Trend Watch September 12, 2023
Share

As we highlighted last week, September is Gynecological Cancer Awareness Month. After exploring the landscape of challenges and opportunities in gynecological cancer treatment, this week we’re zeroing in on Ovarian Cancer. Specifically, we’ll introduce you to the startups making waves in diagnostics and care for this often-fatal condition. A Quick Recap: What is Ovarian Cancer? Ovarian cancer originates in the ovaries, the female reproductive glands responsible…

Innovation in Gynecological Cancer Diagnostics and Care

Cancer, News, Trend Watch September 6, 2023
Share

September is recognized as Gynecological Cancer Awareness Month, making it an especially important time to focus on these significant health issues affecting women. Gynecological cancers are a significant concern in women’s health, affecting millions globally each year. These cancers are unique to the female reproductive system and can manifest in various ways, depending on the organ affected. Early detection and treatment are critical for…

Nevia Bio Secures $3M in Seed Funding to Advance Machine Learning in Women’s Health Diagnostics

Cancer, Investment, News, Women's Health August 30, 2023
Share

Israel-based Nevia Bio has raised $3.1M in seed funding to accelerate its mission to revolutionize the early detection of diseases affecting women. The startup, which has rebranded from its former name Gina Life, specializes in developing machine learning algorithms capable of identifying early indicators of women’s health issues, such as ovarian cancer. The latest funding round saw participation from MindUP Digital Health…

Delphinus Raises $12M for Its 3D Whole Breast Ultrasound Tomography System to Invest in Further Expansion

Breast Health, Cancer, Investment, News August 23, 2023
Share

Delphinus Medical Technologies, a pioneer in dense breast medical imaging, has secured $12M in growth capital from Trinity Capital. The funding will accelerate the adoption of their SoftVue 3D Whole Breast Tomography System, which enhances early breast cancer detection. The SoftVue system gained FDA approval in 2021 as an adjunct to digital mammography for screening asymptomatic women with dense breast tissue. Addressing…